Perfect Medical Health Management (SEHK:1830) Stock Faces Five Year 10.6% Earnings Decline Narrative Test

Perfect Medical Health Management (SEHK:1830) has posted its latest FY 2026 figures with first half revenue of HK$485.9 million and basic EPS of HK$0.08, alongside net income of HK$94.8 million, setting the stage for a results season where profitability remains firmly in focus. Over recent periods, the company has seen revenue move from HK$620.3 million in 1H FY 2025 to HK$507.6 million in 2H FY 2025 and then to HK$485.9 million in 1H FY 2026. Basic EPS shifted from HK$0.11 to HK$0.05 and then HK$0.08 over the same halves, giving investors a clear view of how the top and bottom lines have tracked through the last three reporting periods. With trailing net margins in the high teens, this earnings release places profitability quality and resilience at the center of the story for shareholders.

See our full analysis for Perfect Medical Health Management.

With the headline numbers on the table, the next step is to see how these results line up with the widely followed narratives around Perfect Medical Health Management, and where the data may start to challenge existing views.

Curious how numbers become stories that shape markets? Explore Community Narratives

Trailing EPS Slide To HK$0.142 Raises Questions

• On a trailing 12 month basis, Basic EPS has moved from HK$0.164699 at 2H FY 2025 to HK$0.142 at 2H FY 2026, alongside a reported 10.6% annualised decline in earnings over the past five years.
• Bears highlight that a 10.6% per year decline in earnings over five years lines up with the softer trailing EPS,
  • and point to the drop in trailing net income from HK$206.9 million at 2H FY 2025 to HK$178.7 million at 2H FY 2026 as evidence that Perfect Medical Health Management has been facing pressure on profit growth.

For investors worried about this multi year earnings slide, a dedicated bear case can help frame the risks in more detail 🐻 Perfect Medical Health Management Bear Case.

18.5% Net Margin Shows Profitability Holding Up

• Trailing net profit margin of 18.5% is fractionally higher than the 18.3% reported a year earlier, even as trailing 12 month revenue stepped down from HK$1,127.9 million at 2H FY 2025 to HK$965.4 million at 2H FY 2026.
• Bulls argue that margins around the high teens support the idea of a resilient service model,
  • and the combination of HK$178.7 million in trailing net income with that 18.5% margin gives some backing to the bullish view that Perfect Medical Health Management is still converting a meaningful share of its revenue into profit despite the earnings decline over several years.

If you want to see how supporters connect this margin profile to a longer term growth story, the bullish narrative breaks it down in more detail 🐂 Perfect Medical Health Management Bull Case.

P/E Of 7.6x Versus DCF Fair Value Gap

• At a share price of HK$1.08, Perfect Medical Health Management is trading on a P/E of 7.6x compared with a peer average of 56.5x and a DCF fair value of HK$5.45, which implies a very large gap between market price and that valuation model.
• What stands out for valuation focused investors is the tension between a reported multiyear earnings decline and this low multiple,
  • because the roughly 80% discount to the HK$5.45 DCF fair value and a P/E above the 5.8x Hong Kong Consumer Services industry average suggest the market may be weighing both the historical earnings pressure and the company’s current profitability when pricing the stock.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Perfect Medical Health Management's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

After weighing both the pressure on earnings and the resilient margins at Perfect Medical Health Management, now is a good time to examine the data yourself, consider both sides of the story and see the 1 key reward and 2 important warning signs.

See What Else Is Out There

Perfect Medical Health Management has faced a multi year slide in earnings, with trailing EPS and net income both trending lower while revenue has softened.

If this weaker earnings profile concerns you, use the 187 high quality undervalued stocks to quickly spot other companies where solid financials and pricing might line up more closely with your expectations.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com